Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cortex ; 99: 358-374, 2018 02.
Article in English | MEDLINE | ID: mdl-29353121

ABSTRACT

Apraxia of speech is a motor speech disorder characterized by combinations of slow speaking rate, abnormal prosody, distorted sound substitutions, and trial-and-error articulatory movements. Apraxia of speech is due to abnormal planning and/or programming of speech production. It is referred to as primary progressive apraxia of speech (PPAOS) when it is the only symptom of a neurodegenerative condition. Past reports suggest an association of PPAOS with primary 4-repeat (4R) tau (e.g., progressive supranuclear palsy, corticobasal degeneration), rather than amyloid, pathology. The goal of the current study was to investigate the distribution of tau tracer uptake using [18F]AV-1451 positron emission tomography (PET) imaging in patients with PPAOS. Fourteen PPAOS patients underwent [18F]AV-1451 PET (tau-PET) imaging, [C11] Pittsburgh Compound B (PiB) PET and structural MRI and were matched 3:1 by age and sex to 42 cognitively normal controls. Tau-PET uptake was assessed at the region-of-interest (ROI) level and at the voxel-level. The PPAOS group (n = 14) showed increased tau-PET uptake in the precentral gyrus, supplementary motor area and Broca's area compared to controls. To examine whether tau deposition in Broca's area was related to the presence of aphasia, we examined a subgroup of the PPAOS patients who had predominant apraxia of speech, with concomitant aphasia (PPAOSa; n = 7). The PPAOSa patients showed tau-PET uptake in the same regions as the whole group. However, the remaining seven patients who did not have aphasia showed uptake only in superior premotor and precentral cortices, with no uptake observed in Broca's area. This cross-sectional study demonstrates that elevated tau tracer uptake is observed using [18F]AV-1451 in PPAOS. Further, it appears that [18F]AV-1451 is sensitive to the regional distribution of tau deposition in different stages of PPAOS, given the relationship between tau signal in Broca's area and the presence of aphasia.


Subject(s)
Aphasia/diagnostic imaging , Apraxias/diagnostic imaging , Brain/diagnostic imaging , tau Proteins/metabolism , Aged , Aged, 80 and over , Amyloid/metabolism , Aniline Compounds , Aphasia/metabolism , Brain/metabolism , Broca Area/diagnostic imaging , Broca Area/metabolism , Carbolines , Case-Control Studies , Contrast Media , Cross-Sectional Studies , Disease Progression , Female , Frontal Lobe/diagnostic imaging , Frontal Lobe/metabolism , Humans , Male , Middle Aged , Motor Cortex/diagnostic imaging , Motor Cortex/metabolism , Positron-Emission Tomography , Thiazoles
2.
J Comp Neurol ; 526(5): 920-931, 2018 04 01.
Article in English | MEDLINE | ID: mdl-29230808

ABSTRACT

Although the concept of left-hemispheric lateralization of neural processes during speech production has been known since the times of Broca, its physiological underpinnings still remain elusive. We sought to assess the modulatory influences of a major neurotransmitter, dopamine, on hemispheric lateralization during real-life speaking using a multimodal analysis of functional MRI, intracranial EEG recordings, and large-scale neural population simulations based on diffusion-weighted MRI. We demonstrate that speech-induced phasic dopamine release into the dorsal striatum and speech motor cortex exerts direct modulation of neuronal activity in these regions and drives left-hemispheric lateralization of speech production network. Dopamine-induced lateralization of functional activity and networks during speaking is not dependent on lateralization of structural nigro-striatal and nigro-motocortical pathways. Our findings provide the first mechanistic explanation for left-hemispheric lateralization of human speech that is due to left-lateralized dopaminergic modulation of brain activity and functional networks.


Subject(s)
Brain Mapping , Broca Area , Dopamine/metabolism , Functional Laterality/physiology , Speech/physiology , Adult , Aged , Broca Area/diagnostic imaging , Broca Area/metabolism , Broca Area/physiology , Electroencephalography , Female , Humans , Imaging, Three-Dimensional , Magnetic Resonance Imaging , Male , Middle Aged , Motor Cortex/drug effects , Motor Cortex/physiology
3.
Sci Rep ; 6: 25808, 2016 05 11.
Article in English | MEDLINE | ID: mdl-27165547

ABSTRACT

The glomerular layer of the olfactory bulb (OB) receives heavy cholinergic input from the horizontal limb of the diagonal band of Broca (HDB) and expresses both muscarinic and nicotinic acetylcholine (ACh) receptors. However, the effects of ACh on OB glomerular odor responses remain unknown. Using calcium imaging in transgenic mice expressing the calcium indicator GCaMP2 in the mitral/tufted cells, we investigated the effect of ACh on the glomerular responses to increasing odor concentrations. Using HDB electrical stimulation and in vivo pharmacology, we find that increased OB ACh leads to dynamic, activity-dependent bi-directional modulation of glomerular odor response due to the combinatorial effects of both muscarinic and nicotinic activation. Using pharmacological manipulation to reveal the individual receptor type contributions, we find that m2 muscarinic receptor activation increases glomerular sensitivity to weak odor input whereas nicotinic receptor activation decreases sensitivity to strong input. Overall, we found that ACh in the OB increases glomerular sensitivity to odors and decreases activation thresholds. This effect, along with the decreased responses to strong odor input, reduces the response intensity range of individual glomeruli to increasing concentration making them more similar across the entire concentration range. As a result, odor representations are more similar as concentration increases.


Subject(s)
Acetylcholine/metabolism , Odorants , Olfactory Bulb/metabolism , Animals , Broca Area/drug effects , Broca Area/metabolism , Cholinergic Agents/pharmacology , Female , Male , Mice , Neostigmine/pharmacology , Olfactory Bulb/drug effects , Pentanoic Acids/pharmacology , Receptors, Muscarinic/metabolism , Receptors, Nicotinic/metabolism
4.
Cortex ; 66: 46-59, 2015 May.
Article in English | MEDLINE | ID: mdl-25797658

ABSTRACT

Neuroimaging techniques, such as fMRI, structural MRI, diffusion tensor imaging (DTI), and proton magnetic resonance spectroscopy (1H-MRS) have uncovered evidence for widespread functional and anatomical brain abnormalities in autism spectrum disorder (ASD) suggesting it to be a system-wide neural systems disorder. Nevertheless, most previous studies have focused on examining one index of neuropathology through a single neuroimaging modality, and seldom using multiple modalities to examine the same cohort of individuals. The current study aims to bring together multiple brain imaging modalities (structural MRI, DTI, and 1H-MRS) to investigate the neural architecture in the same set of individuals (19 high-functioning adults with ASD and 18 typically developing (TD) peers). Morphometry analysis revealed increased cortical thickness in ASD participants, relative to typical controls, across the left cingulate, left pars opercularis of the inferior frontal gyrus, left inferior temporal cortex, and right precuneus, and reduced cortical thickness in right cuneus and right precentral gyrus. ASD adults also had reduced fractional anisotropy (FA) and increased radial diffusivity (RD) for two clusters on the forceps minor of the corpus callosum, revealed by DTI analyses. 1H-MRS results showed a reduction in the N-acetylaspartate/Creatine ratio in dorsal anterior cingulate cortex (dACC) in ASD participants. A decision tree classification analysis across the three modalities resulted in classification accuracy of 91.9% with FA, RD, and cortical thickness as key predictors. Examining the same cohort of adults with ASD and their TD peers, this study found alterations in cortical thickness, white matter (WM) connectivity, and neurochemical concentration in ASD. These findings underscore the potential for multimodal imaging to better inform on the neural characteristics most relevant to the disorder.


Subject(s)
Autism Spectrum Disorder/pathology , Brain/pathology , White Matter/pathology , Adult , Anisotropy , Aspartic Acid/analogs & derivatives , Aspartic Acid/metabolism , Autism Spectrum Disorder/metabolism , Autism Spectrum Disorder/physiopathology , Brain/metabolism , Brain/physiopathology , Broca Area/metabolism , Broca Area/pathology , Broca Area/physiopathology , Case-Control Studies , Corpus Callosum/metabolism , Corpus Callosum/pathology , Corpus Callosum/physiopathology , Creatine/metabolism , Diffusion Tensor Imaging , Female , Functional Neuroimaging , Gyrus Cinguli/metabolism , Gyrus Cinguli/pathology , Gyrus Cinguli/physiopathology , Humans , Magnetic Resonance Imaging , Magnetic Resonance Spectroscopy , Male , Multimodal Imaging , Neural Pathways , Organ Size , Parietal Lobe/metabolism , Parietal Lobe/pathology , Parietal Lobe/physiopathology , Prefrontal Cortex/metabolism , Prefrontal Cortex/pathology , Prefrontal Cortex/physiopathology , Temporal Lobe/metabolism , Temporal Lobe/pathology , Temporal Lobe/physiopathology , White Matter/metabolism , White Matter/physiopathology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...